Cargando…

Acute Myocarditis Following mRNA-1273 SARS-CoV-2 Vaccination

Myocarditis has been described previously as a rare side effect of both influenza and smallpox vaccines. In this report, we present a case of acute perimyocarditis in a young, healthy man after vaccination with the mRNA-1273 severe acute respiratory syndrome coronavirus -2 (SARS-CoV-2; Moderna) vacc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, Curtis B., Choi, Jung-in, Hosseini, Farshad, Roberts, James, Ramanathan, Krishnan, Ong, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278869/ https://www.ncbi.nlm.nih.gov/pubmed/34308326 http://dx.doi.org/10.1016/j.cjco.2021.07.008

Ejemplares similares

Myocarditis following COVID‐19 mRNA (mRNA‐1273) vaccination
por: Chellapandian, Suresh Babu, et al.
Publicado: (2022)

Acute Myocarditis in a Patient Following mRNA-1273 SARS-CoV-2 Vaccination
por: Kawakami, Toshinaru, et al.
Publicado: (2022)

mRNA-1273: Myocarditis: case report
Publicado: (2021)

Acute Myocarditis Following Vaccination With the First Dose of the mRNA-1273 Vaccine
por: Olagunju, Abdulbaril, et al.
Publicado: (2022)

Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine
por: Tailor, Prashant D, et al.
Publicado: (2021)

mRNA-1273/tozinameran: Myocarditis: 6 case reports
Publicado: (2021)

mRNA-1273/tozinameran: Myocarditis: 3 case reports
Publicado: (2021)

mRNA-1273/tozinameran: Myocarditis: 4 case reports
Publicado: (2022)

Acute myocarditis after the third dose of COVID‐19 mRNA‐1273 vaccine
por: Yamada, Takayuki
Publicado: (2023)

2391. Evaluation and Adjudication of Case Reports of Myocarditis After mRNA-1273 Vaccination
por: Urdaneta, Veronica, et al.
Publicado: (2023)

Acute myocarditis after COVID‐19 vaccination with mRNA‐1273 in a patient with former SARS‐CoV‐2 infection
por: Nguyen, Tien Dung, et al.
Publicado: (2021)

Case report: SARS-CoV-2 specific T-cells are associated with myocarditis after COVID-19 vaccination with mRNA-1273
por: Stervbo, Ulrik, et al.
Publicado: (2023)

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
por: Baden, Lindsey R., et al.
Publicado: (2020)

Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents
por: Ali, Kashif, et al.
Publicado: (2021)

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
por: Widge, Alicia T., et al.
Publicado: (2020)

mrna-1273: Acute myocarditis: case report
Publicado: (2021)

mRNA-1273/tozinameran: Acute myocarditis: 5 case reports
Publicado: (2022)

Immunogenicity of Sars-Cov-2 mRNA 1273 Vaccine in Patients with Lymphoid Malignancies
por: Dong, Ning, et al.
Publicado: (2021)

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
por: Anderson, Evan J., et al.
Publicado: (2020)

Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide
por: Straus, Walter, et al.
Publicado: (2022)

mrna-1273/tozinameran: Myocarditis: 8 case reports
Publicado: (2021)

A 17-year-old male with acute myocarditis following mRNA-1273 vaccination in Japan
por: Iwamuro, Ayumi, et al.
Publicado: (2022)

Myocarditis After the Third Dose of mRNA-1273 Coronavirus Disease 2019 (COVID-19) Vaccine
por: Kawahara, Hiroshi, et al.
Publicado: (2022)

Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination
por: Goddard, Kristin, et al.
Publicado: (2022)

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
por: Corbett, Kizzmekia S., et al.
Publicado: (2020)

Parsonage Turner Syndrome Following Vaccination With mRNA-1273 SARS-CoV-2 Vaccine
por: Bernheimer, James H., et al.
Publicado: (2022)

Small-Fiber Neuropathy After Vaccination With mRNA-1273 SARS-CoV-2 Vaccine
por: Bernheimer, James H., et al.
Publicado: (2023)

A short discussion about the SARS-CoV-2 mRNA-1273 vaccine
por: Oronsky, Bryan, et al.
Publicado: (2021)

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
por: El Sahly, Hana M., et al.
Publicado: (2021)

Eosinophilic Granulomatosis with Polyangiitis after mRNA-1273 SARS-CoV-2 Vaccine
por: Mencarelli, Lucrezia, et al.
Publicado: (2023)

Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccine
por: Lopes de Assis, Felipe, et al.
Publicado: (2023)

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
por: Pajon, Rolando, et al.
Publicado: (2022)

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants
por: Pegu, Amarendra, et al.
Publicado: (2021)

Severe Myocarditis in a Female Following mRNA-1273 Vaccine: A Case Report and Review of the Literature
por: AL-Qudah, Bara M, et al.
Publicado: (2022)

Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2
por: Blumenthal, Kimberly G., et al.
Publicado: (2021)

A Case of Hypophysitis Following Immunization With the mRNA-1273 SARS-CoV-2 Vaccine
por: Murvelashvili, Natia, et al.
Publicado: (2021)

Bell’s Palsy After 24 Hours of mRNA-1273 SARS-CoV-2 Vaccine
por: Iftikhar, Haris, et al.
Publicado: (2021)

Herpes zoster reactivation after mRNA-1273 (Moderna) SARS-CoV-2 vaccination
por: Channa, Leelakrishna, et al.
Publicado: (2021)

mRNA-1273 Vaccine-elicited Neutralization of SARS-CoV-2 Omicron in Adolescents and Children
por: Girard, Bethany, et al.
Publicado: (2022)

Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar
por: Abu-Raddad, Laith J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1vqilh9u6ifd1ksme059413dkl